Literature DB >> 1540549

Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells.

H Yeoman1, A L Mellor.   

Abstract

Transgenic mice carrying a MHC class I structural gene (H-2Kb) linked to transcriptional control elements from the human beta-globin gene, which direct erythroid lineage specific transcription, express H-2Kb molecules in red blood cells but H-2Kb expression cannot be detected in skin or lymphoid cells. This limited pattern of self MHC expression is sufficient to induce tolerance to H-2Kb molecules and H-2Kb restricted cytotoxic T cell responses can be generated in transgenic mice. Transgenic mice are unable to mount H-2Kb specific cytotoxic T cell responses in vitro, even when exogenous IL-2 is provided. However, H-2Kb specific T cell proliferative responses are comparable with H-2Kb specific responses in non-transgenic mice, even in the absence of exogenous IL-2. Thus, expression of H-2Kb molecules under control of human beta-globin transcriptional control elements in transgenic mice is tolerogenic but does not result in elimination of all H-2Kb reactive T cells from the mature repertoire. This suggests that tolerance in these mice may arise due to functional inactivation of H-2Kb reactive T cells in vivo when they encounter H-2Kb molecules expressed on cells of erythroid cell lineages or on non-erythroid cells which express H-2Kb molecules at very low levels or in a developmentally regulated pattern. Furthermore, in spite of the failure to detect H-2Kb expression on non-erythroid cells in these mice, we conclude that H-2Kb molecules participate in positive selection of the T cell repertoire since H-2Kb restricted T cell responses can be generated in these transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540549     DOI: 10.1093/intimm/4.1.59

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes.

Authors:  D T Harris; M J Schumacher; J Locascio; F J Besencon; G B Olson; D DeLuca; L Shenker; J Bard; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.

Authors:  Chaorui Tian; Xueli Yuan; Jessamyn Bagley; Bruce R Blazar; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2008-02-15       Impact factor: 3.969

3.  Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance.

Authors:  Nathan J Robertson; Frances A Brook; Richard L Gardner; Stephen P Cobbold; Herman Waldmann; Paul J Fairchild
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

Review 4.  Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells.

Authors:  Michel Sadelain; Alex Chang; Leszek Lisowski
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

5.  Mannose binding protein is involved in first-line host defence: evidence from transgenic mice.

Authors:  P Tabona; A Mellor; J A Summerfield
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

6.  Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.

Authors:  R Schulz; A L Mellor
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

7.  Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition.

Authors:  Adnan Khan; Hongmei Fu; Lee Aun Tan; Jennifer E Harper; Sven C Beutelspacher; Daniel F P Larkin; Giovanna Lombardi; Myra O McClure; Andrew J T George
Journal:  Eur J Immunol       Date:  2013-01-18       Impact factor: 5.532

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.